Thrivent Financial for Lutherans Lowers Stock Holdings in Select Medical Holdings Co. (NYSE:SEM)

Thrivent Financial for Lutherans lessened its stake in Select Medical Holdings Co. (NYSE:SEM) by 2.3% during the 4th quarter, according to its most recent 13F filing with the Securities & Exchange Commission. The firm owned 80,960 shares of the health services provider’s stock after selling 1,943 shares during the period. Thrivent Financial for Lutherans owned 0.06% of Select Medical worth $1,526,000 as of its most recent SEC filing.

Other institutional investors and hedge funds have also recently added to or reduced their stakes in the company. Geode Capital Management LLC raised its stake in shares of Select Medical by 2.0% during the third quarter. Geode Capital Management LLC now owns 2,442,321 shares of the health services provider’s stock worth $85,180,000 after purchasing an additional 46,880 shares during the last quarter. Principal Financial Group Inc. raised its position in Select Medical by 1.9% during the 4th quarter. Principal Financial Group Inc. now owns 2,403,508 shares of the health services provider’s stock worth $45,310,000 after buying an additional 45,685 shares during the last quarter. Point72 Asset Management L.P. lifted its stake in shares of Select Medical by 144.2% in the 3rd quarter. Point72 Asset Management L.P. now owns 2,059,791 shares of the health services provider’s stock worth $71,825,000 after acquiring an additional 1,216,263 shares during the period. Charles Schwab Investment Management Inc. boosted its holdings in shares of Select Medical by 0.6% in the fourth quarter. Charles Schwab Investment Management Inc. now owns 1,656,320 shares of the health services provider’s stock valued at $31,222,000 after acquiring an additional 10,000 shares in the last quarter. Finally, JPMorgan Chase & Co. increased its stake in shares of Select Medical by 9.7% during the third quarter. JPMorgan Chase & Co. now owns 416,299 shares of the health services provider’s stock worth $14,516,000 after acquiring an additional 36,905 shares during the period. 89.48% of the stock is owned by hedge funds and other institutional investors.

Select Medical Stock Performance

SEM opened at $16.81 on Monday. Select Medical Holdings Co. has a 1-year low of $16.20 and a 1-year high of $40.98. The stock has a market cap of $2.17 billion, a P/E ratio of 10.19, a P/E/G ratio of 0.64 and a beta of 1.56. The stock’s 50 day simple moving average is $18.38 and its 200 day simple moving average is $24.95. The company has a debt-to-equity ratio of 1.37, a current ratio of 1.13 and a quick ratio of 1.13.

Select Medical (NYSE:SEM) last posted its earnings results on Thursday, February 20th. The health services provider reported $0.18 earnings per share for the quarter, missing the consensus estimate of $0.29 by ($0.11). The firm had revenue of $1.31 billion during the quarter, compared to analyst estimates of $1.50 billion. Select Medical had a net margin of 3.23% and a return on equity of 14.04%. As a group, equities analysts anticipate that Select Medical Holdings Co. will post 1.17 EPS for the current fiscal year.

Select Medical Cuts Dividend

The firm also recently declared a quarterly dividend, which was paid on Thursday, March 13th. Shareholders of record on Monday, March 3rd were issued a $0.0625 dividend. This represents a $0.25 annualized dividend and a dividend yield of 1.49%. The ex-dividend date of this dividend was Monday, March 3rd. Select Medical’s dividend payout ratio (DPR) is presently 15.15%.

Wall Street Analyst Weigh In

A number of equities research analysts have weighed in on the company. UBS Group lowered their price objective on Select Medical from $40.00 to $21.00 and set a “neutral” rating on the stock in a report on Friday, January 3rd. StockNews.com upgraded Select Medical from a “hold” rating to a “buy” rating in a research note on Friday, February 21st. Royal Bank of Canada cut their price objective on Select Medical from $47.00 to $23.00 and set an “outperform” rating for the company in a research report on Monday, February 24th. Finally, Benchmark upgraded shares of Select Medical from a “hold” rating to a “buy” rating and set a $23.00 target price on the stock in a research report on Monday, February 24th. One research analyst has rated the stock with a hold rating and four have given a buy rating to the company. Based on data from MarketBeat.com, Select Medical currently has a consensus rating of “Moderate Buy” and an average target price of $27.25.

Select Medical Profile

Select Medical Holdings Corporation, through its subsidiaries, operates critical illness recovery hospitals, rehabilitation hospitals, outpatient rehabilitation clinics, and occupational health centers in the United States. It operates in four segments: Critical Illness Recovery Hospital, Rehabilitation Hospital, Outpatient Rehabilitation, and Concentra.